SCICLONE PHARMA News

SCICLONE PHARMA: ANNOUNCEMENT PURSUANT TO RULE 3.8 OF THE TAKEOVERS CODE

Apr 26 09:43 ET

SCICLONE PHARMA: PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND CHANGE OF DATE OF ANNUAL GENERAL MEETING AND BOOK CLOSURE PERIOD

Apr 25 07:12 ET

SCICLONE PHARMA: ANNOUNCEMENT PURSUANT TO RULE 3.8 OF THE TAKEOVERS CODE

Apr 23 10:23 ET

SCICLONE PHARMA: ANNOUNCEMENT PURSUANT TO RULE 3.8 OF THE TAKEOVERS CODE

Apr 22 09:56 ET

SCICLONE PHARMA: ANNOUNCEMENT PURSUANT TO RULE 3.8 OF THE TAKEOVERS CODE

Apr 19 10:50 ET

SCICLONE PHARMA: Disclosure of Dealings under Rule 22 of the Takeovers Code

Apr 19 04:45 ET

SCICLONE PHARMA: Disclosure of Dealings under Rule 22 of the Takeovers Code

Apr 19 04:45 ET

SCICLONE PHARMA: Disclosure of Dealings under Rule 22 of the Takeovers Code

Apr 19 04:45 ET

SCICLONE PHARMA: Disclosure of Dealings under Rule 22 of the Takeovers Code

Apr 19 04:45 ET

SCICLONE PHARMA: Disclosure of Dealings under Rule 22 of the Takeovers Code

Apr 19 04:45 ET

SCICLONE PHARMA: ANNOUNCEMENT PURSUANT TO RULE 3.8 OF THE TAKEOVERS CODE

Apr 18 10:50 ET

SCICLONE PHARMA: Disclosure of Dealings under Rule 22 of the Takeovers Code

Apr 18 04:38 ET

SCICLONE PHARMA: Disclosure of Dealings under Rule 22 of the Takeovers Code

Apr 18 04:38 ET

SCICLONE PHARMA: Disclosure of Dealings under Rule 22 of the Takeovers Code

Apr 18 04:38 ET

SCICLONE PHARMA: Disclosure of Dealings under Rule 22 of the Takeovers Code

Apr 18 04:38 ET

SCICLONE PHARMA: Disclosure of Dealings under Rule 22 of the Takeovers Code

Apr 18 04:38 ET

SCICLONE PHARMA: (1) PROPOSAL FOR THE PRIVATISATION OF SCICLONE PHARMACEUTICALS (HOLDINGS) LIMITED BY SILVER PEGASUS INVESTMENT LIMITED BY WAY OF A SCHEME OF ARRANGEMENT (UNDER SECTION 86 OF THE COMPANIES ACT) (2) PROPOSED WITHDRAWAL OF LISTING OF SCICLONE PHARMACEUTICALS

Apr 18 04:31 ET

SCICLONE PHARMA: ANNOUNCEMENT PURSUANT TO RULE 3.8 OF THE TAKEOVERS CODE

Apr 17 09:54 ET

SCICLONE PHARMA: Disclosure of Dealings under Rule 22 of the Takeovers Code

Apr 17 05:27 ET

SCICLONE PHARMA: Disclosure of Dealings under Rule 22 of the Takeovers Code

Apr 17 05:27 ET